Leishmaniasis is a parasitic disease that presents four main clinical syndromes: cutaneous
leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), visceral leishmaniasis/kala azar …

Marine sponges have been considered as a drug treasure house with respect to great
potential regarding their secondary metabolites. Most of the studies have been conducted …

The peer-reviewed marine pharmacology literature in 2007–8 is covered in this review,
which follows a similar format to the previous 1998–2006 reviews of this series. The …

Covering: 2008. Previous review: Nat. Prod. Rep., 2009, 26, 170This review covers the
literature published in 2008 for marine natural products, with 829 citations (613 for the …

Leishmaniasis, a group of diseases caused by hemoflagellate obligate intracellular protozoa
(trypanosomatids) from the genus Leishmania, has not received the attention it deserves …

Covering period: up to 2019 Water-soluble natural products constitute a relevant group of
secondary metabolites notably known for presenting potent biological activities. Examples …

Leishmaniasis is a neglected infectious disease caused by kinetoplastid protozoans. An
urgent need for novel chemotherapeutics exists. The current approaches to discover new …

Thirteen undescribed phenanthrene and bibenzyl derivatives, named blestanols AM,
including one pair of biphenanthrene enantiomers, two bis 9, 10-dihydrophenanthrene …

The marine environment represents a relatively available source of functional ingredients
that can be applied to various aspects of food processing, storage, and fortification …

Seven norsesterterpene peroxides: epimuqubilin A (1), muqubilone B (2), unnamed cyclic
peroxide ester (3), epimuqubilin B (4), sigmosceptrellin A methyl ester (5), sigmosceptrellin …